J Nucl Cardiol. 2012 Aug;19(4):649-57. doi: 10.1007/s12350-012-9578-x.
Coronary CT angiography (CCTA) has matured to be a fast noninvasive imaging test in the evaluation of coronary artery disease (CAD). It has demonstrated excellent accuracy for defining the presence and the severity of luminal coronary artery stenoses and is probably the best noninvasive test to reliably exclude atherosclerotic coronary disease. Furthermore, accumulating CCTA data indicate that it can identify individuals at risk for all-cause mortality. It is also well known that despite the wealth of data regarding diagnostic and prognostic values of stress testing in CAD, up to 10% of stress imaging studies are considered inconclusive, leading to subsequent invasive coronary angiography for definitive diagnosis often with negative results. Moreover, recent data indicate that up to 30 % of patients undergoing angiography have no significant CAD despite a majority of them having had a prior stress test. Whether CCTA can serve as a cost-effective methodology to invasive angiography has been a source of active research. In this context, we will discuss the implications of the recently published data from the Advanced Cardiovascular Imaging Consortium registry looking at the use of CCTA after stress testing in Michigan.
冠状动脉 CT 血管造影(CCTA)已发展成为评估冠状动脉疾病(CAD)的一种快速、非侵入性的影像学检查方法。它在定义管腔冠状动脉狭窄的存在和严重程度方面具有出色的准确性,可能是可靠排除动脉粥样硬化性冠状动脉疾病的最佳非侵入性检查方法。此外,越来越多的 CCTA 数据表明,它可以识别出全因死亡率风险较高的个体。尽管关于 CAD 中应激测试的诊断和预后价值的数据丰富,但多达 10%的应激成像研究被认为是不确定的,这导致随后进行有创性冠状动脉血管造影以明确诊断,通常结果为阴性。此外,最近的数据表明,尽管大多数患者之前进行过应激测试,但仍有多达 30%的接受血管造影的患者没有明显的 CAD。CCTA 是否可以作为一种具有成本效益的侵袭性血管造影方法一直是活跃研究的主题。在这方面,我们将讨论密歇根州先进心血管成像联盟注册中心最近公布的数据对在应激测试后使用 CCTA 的影响。